HOME >> MEDICINE >> NEWS
Swedish trials suggest modest benefit for screening mammography

New data with longer follow-up from four Swedish trials published in this weeks issue of THE LANCET suggests there may be a modest benefit from screening mammography for women aged 55 years or over.

Considerable debate surrounds the issue of screening mammography and its possible benefits. A research letter by Ole Olsen and Peter Gotzsche (Lancet 2001; 358: 1340-42) concluded that there was no reliable evidence from randomised trials to support the benefit of screening mammography. Lennarth Nystrom and colleagues from the University of Umea, Sweden, present new data updating the overview of four Swedish randomised controlled trials on mammography screening up to and including 1996. The study also contains data from the trials that have not been presented before.

The trials include data for about 247,000 women, who were followed-up by record linkage to the Swedish Cancer and Cause of Death Registers. The relative risks for breast cancer death and death from all causes were calculated for women given screening mammography and those not invited for screening (the control groups in the four trials).

Average follow-up time for the trials was 15.8 years. There were 511 breast cancer deaths in 1 864 770 women-years in the groups given mammography, and 584 breast cancer deaths in 1 688 440 women-years in the control groupsresulting in a significant 21% reduction in breast cancer mortality for women given screening mammography. The reduction was greatest (33%)in the age group 6069 years at entry to the trials. There were statistically significant effects in the age groups 5559, 6064, and 6569 years, but there was only a small relative risk reduction (5%) in women aged 50-54 years. The benefit in terms of cumulative breast cancer mortality started to emerge at about 4 years after randomisation and continued to increase to about 10 years. There was no significant difference in death from all causes between screening and control groups.

Lenna
'"/>

Contact: Richard Lane
richard.lane@lancet.com
44-20-7424-4949
Lancet
14-Mar-2002


Page: 1 2

Related medicine news :

1. Promising new strategy for Swedish medical research
2. Hopkins begins human trials with donor adult stem cells to repair muscle damaged from heart attack
3. US attempting to flout ethical practice for patient trials abroad
4. New trials for counseling caregivers and patients with Alzheimers begin
5. NIAID seeks applicants to lead clinical trials units for revamped HIV/AIDS networks
6. New ITN Scholars Program provides junior faculty opportunity to develop clinical trials expertise
7. OHSU researcher says FDA could broaden access to results of clinical drug trials
8. Success of experimental herpes vaccine builds momentum for human clinical trials
9. Re-analysis of large trials shows greatest benefit of chemotherapy in ER-negative tumors
10. Establishing pediatric stroke trials
11. NIAID seeks applicants to lead revamped HIV/AIDS clinical trials networks

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/21/2017)... ... 21, 2017 , ... The Visiting Nurse Association of ... R. Bard Foundation, Inc. to support the music therapy program offered at ... the nonprofit home care agency. Using evidence-based methods, professionally trained and certified music ...
(Date:7/21/2017)... ... July 21, 2017 , ... ... Tears® EyeMist®, the signature product of her research center at Bio-Logic Aqua Research® ... largest population and the greatest number of sufferers of blindness. “We think that ...
(Date:7/21/2017)... TORONTO, ONTARIO, CANADA (PRWEB) , ... July 21, ... ... repair a torn anterior cruciate ligament (ACL) offer patients improved quality of life ... Orthopaedic Society for Sports Medicine’s Annual Meeting in Toronto, Ontario, Canada. The ...
(Date:7/20/2017)... Va. (PRWEB) , ... July 20, 2017 , ... ... McCarter, MD, has joined JenCare Senior Medical Center as Richmond Chief Medical ... Virginia School of Medicine, and Associate Chief Medical Officer of Ambulatory Services for the ...
(Date:7/20/2017)... (PRWEB) , ... July 20, 2017 , ... ... law firm headquartered in Houston, is pleased to announce their expansion to the ... affordable housing experience, directors Alysse Hollis and Ronald Bell, and of counsels, John ...
Breaking Medicine News(10 mins):
(Date:7/21/2017)... -- Endo International plc (NASDAQ: ENDP ) today ... manufacturing network, the Company will be ceasing operations and ... Huntsville, Alabama . The closure of the facilities ... to 18 months. The Huntsville ... products and these restructuring actions are intended to better ...
(Date:7/20/2017)... -- Prime Therapeutics LLC (Prime) released this statement from its Chief ... for Clinical and Economic Review,s (ICER) public meeting ... of abuse-deterrent formulations (ADF) of opioids. Prime was the sole ... "The ICER data ... use of abuse-deterrent formulations (ADF) in opioids in terms of ...
(Date:7/17/2017)... , July 17, 2017  MedX Holdings, Inc., ... medical testing, strengthening and rehabilitation equipment, today announced the ... Program. MedX is considered the gold standard for the ... in specialized medical strengthening equipment. ... lease with the physician or practice who prescribe the ...
Breaking Medicine Technology:
Cached News: